Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Esophageal Neoplasms × Azacitidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 336 Myelodysplastic Syndromes 147 Leukemia, Myelomonocytic, Chronic 68 Leukemia 60 Recurrence 28 Myeloproliferative Disorders 20 Neoplasms 19 Hematologic Neoplasms 17 Lymphoma, Non-Hodgkin 16 Lymphoma 16 Carcinoma, Non-Small-Cell Lung 16 Multiple Myeloma 14 Anemia, Refractory, with Excess of Blasts 14 Lymphoma, T-Cell, Peripheral 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Neoplasm, Residual 12 Lymphoma, Large B-Cell, Diffuse 12 Leukemia, Lymphocytic, Chronic, B-Cell 11 Leukemia, Biphenotypic, Acute 11 Primary Myelofibrosis 10 Leukemia, Monocytic, Acute 9 Hodgkin Disease 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Myelodysplastic-Myeloproliferative Diseases 8 Leukemia, Myelomonocytic, Acute 8 Leukemia, Erythroblastic, Acute 8 Breast Neoplasms 8 Neoplasm Metastasis 7 Lymphoma, Follicular 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7

Interventions

Cisplatin 146 Fluorouracil 123 Paclitaxel 114 Radiotherapy 105 Oxaliplatin 80 Docetaxel 65 Carboplatin 60 Irinotecan 55 pembrolizumab 53 Leucovorin 53 Capecitabine 52 Radiation 42 Surgical Procedures, Operative 31 Esophagectomy 27 Drug Therapy 27 Cetuximab 24 Nivolumab 21 Bevacizumab 21 Trastuzumab 19 Neoadjuvant Therapy 19 camrelizumab 17 S 1 (combination) 17 Chemoradiotherapy 16 Albumin-Bound Paclitaxel 16 Magnetic Resonance Spectroscopy 14 tislelizumab 13 Epirubicin 13 Cyclophosphamide 13 Taxes 12 Radiotherapy, Intensity-Modulated 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01386346 2018-12-12

VEOX

Weill Medical College of Cornell University

Phase 1 Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡